Isolation and Identification of 3,4-Seco-Solanidine-3,4-dioic Acid as a Urinary Biomarker of CYP2D6 Activity is a research paper published in Drug Metabolism and Disposition (2022). On theSindex it has a DataRank of 0. It has been cited 19 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NIGMS NIH HHS
Grant: P30 GM110761
NICHD NIH HHS
Grant: R01 HD058556
NCRR NIH HHS
Grant: S10 RR024664
National Institutes of Health
Grant: 5R01HD058556-02
Exogenous and Endogenous Biomarkers of CYP2D6 Variability in Pediatrics
National Institutes of Health
Grant: 5P30GM110761-04
Protein Structure and Function
National Institutes of Health
Grant: 1S10RR024664-01
Avance II 500 High Performance Digital NMR Spectrometer System
Fields of Study
Keywords
Additional file 1 of Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity
Additional file 1 of Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity